Latest News & Features
Americas
The US Federal Trade Commission has approved a final order that Teva’s acquisition of Allergan’s generic pharmaceutical business for $40.5 billion would be anticompetitive. 16 September 2016
Big Pharma
Ahead of the Life Sciences IP Summit 2016 from October 20 to 21 at the Hilton London Paddington Hotel, Sarah Porch of C5 previews the main talking points, including Brexit and the UPC. 16 September 2016
Biotechnology
Pharmaceutical company AbbVie has had its application to strike out a patent case filed against it by Fujifilm Kyowa Kirin Biologics dismissed. 15 September 2016
Americas
Pharmaceutical company Allergan is set to acquire clinical-stage biotechnology company Vitae Pharmaceuticals for $639 million. 15 September 2016
Americas
Peru has accepted the 2005 protocol amendment to TRIPS, a provision designed to ease poor countries’ access to affordable medicines. 14 September 2016
Americas
Irish drugs producer Horizon Pharma has entered into a definitive agreement with Raptor Pharmaceuticals in which Horizon will buy the US biopharmaceutical company for $800 million. 14 September 2016
Big Pharma
The pharmaceutical industry needs to adjust its expectations of the scope of IP protection available in the digital age, say Stephen Bennett, Elisabethann Wright and Mark Marfe of Hogan Lovells, and James Cross of RGC Jenkins. 13 September 2016
Americas
Biosimilars company Apobiologix has won a patent infringement litigation against Amgen centring on the drugs Grastofil and Lapelga. 13 September 2016
Asia
Pfizer has sued Indian generic company Sun Pharma for allegedly infringing patents centring on Xeljanz, a treatment for rheumatoid arthritis. 13 September 2016
Americas
A man has been arrested by special agents from US Immigration and Customs Enforcement’s Homeland Security Investigations unit for selling illicit goods, including counterfeit pharmaceuticals. 13 September 2016